[Federal Register Volume 69, Number 90 (Monday, May 10, 2004)]
[Notices]
[Page 25909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10536]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04173]


Epidemiological Follow-Up of Thyroid Disease in Persons Exposed 
to Radioactive Fallout From Atomic Weapons Testing at the Nevada Test 
Site; Notice of Intent To Fund Single Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2004 funds for a grant program to study 
the prevalence of thyroid disorders and cancers in adults, who, as 
children, were exposed to radioactive fallout from the nuclear device 
testing at the Nevada Test Site, 1944-1957. The study is designed to 
provide a third (Phase III) diagnostic examination of the thyroid gland 
(approximately 55 years post exposure). The Catalog of Federal Domestic 
Assistance number for this program is 93.283.

B. Eligible Applicant

    Assistance will be provided only to The University of Utah, Salt 
Lake City, Utah. The University of Utah, under a previous five-year 
cooperative agreement and a one-year continuation, initiated data 
collection activities. They are prepared to initiate activities for 
Phase III of the Utah Thyroid Disease Study. To date the University of 
Utah has completed:
    1. Developing training materials for the field team.
    2. Hired the first of three field teams to perform medical exams.
    3. Identified physicians need to perform biopsies of the thyroid 
gland.
    4. Updated the exposure (dose) model algorithm.
    5. Revised exposures estimated during Phase II.
    6. Completed the identification of subjects needed for the 
mortality study.
    7. Begun to locate and identify the study cohort.
    It is in the best interest of the CDC to continue funding the 
University of Utah to completion of the Utah Thyroid Disease Study.

C. Funding

    Approximately $500,000 is available in FY 2004 to fund this award. 
It is expected that the award will begin on or before September 1, 
2004, and will be made for a 12-month budget period and 12-month 
project period. Funding estimates may change.

D. Where to Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For technical questions about this program, contact: Robert C. 
Whitcomb, Jr., Ph.D., Extramural Project Officer, 1600 Clifton Road NE, 
Mail Stop E-39, Atlanta, GA 30333, Telephone: 404-498-1800, E-mail: 
[email protected].

    Dated: May 3, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-10536 Filed 5-7-04; 8:45 am]
BILLING CODE 4163-18-P